BOTULINUM TOXIN TYPE B
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Cervical Dystonia
Conditions
Cervical Dystonia, Spasmodic Torticollis
Trial Timeline
Jun 1, 2004 → Nov 1, 2006
NCT ID
NCT00165776About BOTULINUM TOXIN TYPE B
BOTULINUM TOXIN TYPE B is a phase 2 stage product being developed by Eisai for Cervical Dystonia. The current trial status is completed. This product is registered under clinical trial identifier NCT00165776. Target conditions include Cervical Dystonia, Spasmodic Torticollis.
What happened to similar drugs?
8 of 20 similar drugs in Cervical Dystonia were approved
Approved (8) Terminated (0) Active (12)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00165776 | Phase 2 | Completed |
Competing Products
20 competing products in Cervical Dystonia